BC Partners Puts Up €500M For German Drugmaker
The companies did not disclose financial details of the sale, but a person familiar the matter told Law360 that the deal value was roughly €500 million ($621.1 million).
BC Partners acquired a majority stake in Aenova from Bridgepoint, which originally invested in the health care service provider in 2005. The German company, headquartered just outside Munich, makes oral medicines...
To view the full article, register now.